EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention

Jang-Whan Bae

Cardiovascular Prevention and Pharmacotherapy · 2019

DOI: 10.36011/cpp.2019.1.e1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Prevention and Pharmacotherapy, 2019. Verfasst von Jang-Whan Bae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bae, J. (2019). Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. https://doi.org/10.36011/cpp.2019.1.e1

Vancouver

Bae J. Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. 2019. doi:10.36011/cpp.2019.1.e1

BibTeX
@article{Bae2019,
  author = {Bae, Jang-Whan},
  title = {Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention},
  journal = {Cardiovascular Prevention and Pharmacotherapy},
  year = {2019},
  doi = {10.36011/cpp.2019.1.e1}
}
Kostenlos starten →